FDA Clearance Tracker · P180031-S001
Neuroform Atlas® Stent System
Last checked: Nov 20, 2026Latest source record: Jul 30, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Jul 30, 2020
Approved
Time to decision
374 days
Received Jul 22, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P180031-S001
- Device name
- Neuroform Atlas® Stent System
- Applicant
- Stryker Neurovascular
- Applicant location
- Fremont, CA
- Received
- Jul 22, 2019
- Decided
- Jul 30, 2020
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P180031
Device type
- Device type
- Intracranial coil-assist stent (QCA)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for the Neuroform Atlas Stent System indicated for use with neurovascular embolization coils in the anterior and posterior circulation of the neurovasculature for the endovascular treatment of patients >= 18 years of age with saccular wide-necked (neck width >= 4 mm or a dome-to-neck ratio of < 2) intracranial aneurysms arising from a parent vessel with a diameter of >= 2.0 mm and <= 4.5 mm.
Source documents
Other decisions for Stryker Neurovascular
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261649 · Decided Oct 9, 2026 · 143 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.